CCTN-CONTRACEPTIVE DEVELOPMENT PROGRAM-NICHD CONTRACEPTIVE CLINICAL TRIALS NETWORK-FEMALE SITES-CORE FUNCTION ACTIVITIES

CCTN-避孕发展计划-NICHD避孕临床试验网络-女性站点-核心功能活动

• 批准号: 10895949
• 负责人: MITCHELL CREININ
• 金额: $ 0.2万
• 依托单位: UNIVERSITY OF CALIFORNIA AT DAVIS
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-08-01 至 2024-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10895949
• 关键词: Clinical Trials Network; Conduct Clinical Trials; Contraceptive Agents; Contraceptive methods; Development; Female; Future; Goals; Medical; Methods; Mission; National Institute of Child Health and Human Development; Obesity; Program Development; Protocols documentation; Risk Reduction; Services; Site; Woman; product development; protocol development; unintended pregnancy; venous thromboembolism

There is a demand for new methods of contraception that can provide effective protection against unintended pregnancy as well as reduce the risk of venous thromboembolism (VTE), particularly for obese women. The mission of the Contraceptive Clinical Trials Network (CCTN) is to develop protocols and conduct clinical trials that will assist in product development with the end goal to provide effective and safe contraception for women. The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) has a mission to develop safe and effective contraceptives for women, including obese women and women who have medical conditions for which current contraceptive products are contraindicated.

需要新的避孕方法，可以有效地保护 意外怀孕以及降低静脉血栓栓塞（VTE）的风险，特别是对于 肥胖的女人避孕临床试验网络（CCTN）的使命是开发 协议和进行临床试验，这将有助于产品开发的最终目标， 为妇女提供有效和安全的避孕措施。 尤妮斯·肯尼迪·施莱佛国家儿童健康和人类发展研究所（NICHD） 使命是为妇女，包括肥胖妇女和 目前的医疗状况 避孕产品是禁忌的。